Details for New Drug Application (NDA): 090092
The generic ingredient in ZIDOVUDINE is zidovudine. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the zidovudine profile page.
Summary for 090092
| Tradename: | ZIDOVUDINE |
| Applicant: | Hetero Labs Ltd Iii |
| Ingredient: | zidovudine |
| Patents: | 0 |
Pharmacology for NDA: 090092
| Mechanism of Action | Nucleoside Reverse Transcriptase Inhibitors |
Medical Subject Heading (MeSH) Categories for 090092
Suppliers and Packaging for NDA: 090092
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZIDOVUDINE | zidovudine | TABLET;ORAL | 090092 | ANDA | Camber Pharmaceuticals, Inc. | 31722-509 | 31722-509-60 | 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE |
| ZIDOVUDINE | zidovudine | TABLET;ORAL | 090092 | ANDA | Coupler LLC | 67046-1613 | 67046-1613-3 | 30 TABLET in 1 BLISTER PACK (67046-1613-3) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
| Approval Date: | Apr 25, 2008 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
